Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, reduces mortality and morbidity in children with severe hypertrophic cardiomyopathy (HCM) caused by pathogenic variants in the RAS/MAPK ...

Among the general US population, simple and affordable non-invasive liver fibrosis scoring systems may be able to identify individuals at risk for HF.

Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, reduces mortality and morbidity in children with severe ...

In a large-animal model study, researchers have found that heart attack recovery is aided by the injection of heart muscle ...

The company is trying to develop a one-time treatment for forms of heart disease that afflict more than 1 million people in ...

Fire1 announced today that it completed a $120 million financing round to accelerate the advancement of its heart failure ...

Medically reviewed by Jeffrey S. Lander, MD Living with heart failure requires careful monitoring as well as some major ...

It may open the door to new ways to treat and perhaps someday cure heart failure, the deadliest non-communicable disease on ...

Prof Dhanjal explains that resting heart rate is often reflective of underlying disease which impacts vital bodily systems and organs, because they cause a disruption in the balance between the ...

The SUV is offered in six different variants: HTK, HTK (O), HTK+, HTX, HTX+, and HTX+ (O), and comes with two engine options, namely the 1-litre turbo-petrol and the 1.5-litre diesel engine from ...

Endotheliopathy is an essential part of the pathological response on severe COVID-19, leading to respiratory failure, multiorgan dysfunction, and thrombosis. Endothelial and microvascular damage are ...